IKarisoside A - CAS 55395-07-8
Catalog number:
55395-07-8
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C26H28O10
Molecular Weight:
500.49
COA:
Inquire
Targets:
Others
Description:
IKarisoside A is a natural compound isolated from Epimedium koreanum, which has anti-inflammatory properties.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Synonyms:
Icarisoside-A; Baohuoside II
MSDS:
Inquire
1.Ikarisoside A inhibits acetylcholine-induced catecholamine secretion and synthesis by suppressing nicotinic acetylcholine receptor-ion channels in cultured bovine adrenal medullary cells.
Li X1, Toyohira Y1, Horisita T2, Satoh N3, Takahashi K1, Zhang H4, Iinuma M5, Yoshinaga Y1, Ueno S6, Tsutsui M7, Sata T2, Yanagihara N8. Naunyn Schmiedebergs Arch Pharmacol. 2015 Dec;388(12):1259-69. doi: 10.1007/s00210-015-1161-y. Epub 2015 Aug 11.
Ikarisoside A is a natural flavonol glycoside derived from plants of the genus Epimedium, which have been used in Traditional Chinese Medicine as tonics, antirheumatics, and aphrodisiacs. Here, we report the effects of ikarisoside A and three other flavonol glycosides on catecholamine secretion and synthesis in cultured bovine adrenal medullary cells. We found that ikarisoside A (1-100 μM), but not icariin, epimedin C, or epimedoside A, concentration-dependently inhibited the secretion of catecholamines induced by acetylcholine, a physiological secretagogue and agonist of nicotinic acetylcholine receptors. Ikarisoside A had little effect on catecholamine secretion induced by veratridine and 56 mM K(+). Ikarisoside A (1-100 μM) also inhibited (22)Na(+) influx and (45)Ca(2+) influx induced by acetylcholine in a concentration-dependent manner similar to that of catecholamine secretion. In Xenopus oocytes expressing α3β4 nicotinic acetylcholine receptors, ikarisoside A (0.
2.Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-kappaB signaling pathways.
Choi HJ1, Park YR, Nepal M, Choi BY, Cho NP, Choi SH, Heo SR, Kim HS, Yang MS, Soh Y. Eur J Pharmacol. 2010 Jun 25;636(1-3):28-35. doi: 10.1016/j.ejphar.2010.03.023. Epub 2010 Mar 29.
Osteoclasts are specialized bone-resorbing cells derived from multipotent myeloid progenitor cells. They play a crucial homeostatic role in skeletal modeling and remodeling and destroy bone in many pathologic conditions. Receptor activator of NF-kappaB ligand (RANKL) is essential to osteoclastogenesis. In this study, we investigated the effects of Ikarisoside A, isolated from Epimedium koreanum (Berberidaceae), on osteoclastogenesis in RANKL-treated murine monocyte/macrophage RAW 264.7 cells. The results indicate that Ikarisoside A is a potent inhibitor of osteoclastogenesis in RANKL-stimulated RAW 264.7 cells as well as in bone marrow-derived macrophages. The inhibitory effect of Ikarisoside A resulted in decrease of osteoclast-specific genes like matrix metalloproteinase 9 (MMP9), tartrate-resistant acid phosphatase (TRAP), receptor activator of NF-kappaB (RANK), and cathepsin K. Moreover, Ikarisoside A blocked the resorbing capacity of RAW 264.
3.Ikarisoside A inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated RAW 264.7 cells via p38 kinase and nuclear factor-kappaB signaling pathways.
Choi HJ1, Eun JS, Park YR, Kim DK, Li R, Moon WS, Park JM, Kim HS, Cho NP, Cho SD, Soh Y. Eur J Pharmacol. 2008 Dec 28;601(1-3):171-8. doi: 10.1016/j.ejphar.2008.09.032. Epub 2008 Sep 30.
This study examined the anti-inflammatory properties of Ikarisoside A, isolated from Epimedium koreanum (Berberidaceae), in lipopolysaccharide (LPS)-stimulated macrophages. Ikarisoside A inhibited the expression of LPS-stimulated inducible nitric oxide synthase (iNOS) and the production of nitric oxide (NO) in LPS-stimulated RAW 264.7 cells and mouse bone marrow-derived macrophages (BMMs) in a concentration-dependent manner. In addition, Ikarisoside A reduced the release of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta). Furthermore, Ikarisoside A inhibited the activity of p38 kinase and nuclear factor-kappaB (NF-kappaB), which are signaling molecules involved in NO production. NO production was inhibited when the cells were treated with LPS and either SB 203580 (a p38 inhibitor) or Bay 11-7082 (an inhibitory kappaB kinase 2 inhibitor). These results suggest that Ikarisoside A inhibits the production of NO by inhibiting the activity of p38 MAPK and NF-kappaB.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 102767-28-2 Levetiracetam

Levetiracetam
(CAS: 102767-28-2)

Levetiracetam is an anticonvulsant medication used to treat epilepsy.

CAS 103597-45-1 Diurethane dimethacrylate

Diurethane dimethacrylate
(CAS: 103597-45-1)

Bisoctrizole, a benzotriazole derivative, is a broad-spectrum ultraviolet radiation absorber, absorbing UVB as well as UVA ray. It could also reflect and scatte...

CAS 80681-45-4 Prim-o-glucosylcimifugin

Prim-o-glucosylcimifugin
(CAS: 80681-45-4)

Prim-O-glucosylcimifugin is a natural product extracted from the root of Saposhnikovia divaricata (Turcz.) Schischk. It can inhibit the proliferation of SMC(smo...

CAS 222030-63-9 Fosbretabulin

Fosbretabulin
(CAS: 222030-63-9)

Fosbretabulin, also called as CA4P, has antitumor activity against anaplastic thyroid cancer (ATC) cell lines. Fosbretabulin, a novel water-soluble vascular-dis...

FR-193262
(CAS: 314289-63-9)

A bio-active organic chemical.

CAS 406-90-6 Flurossene

Flurossene
(CAS: 406-90-6)

Fluroxene is a volatile, inhalational anesthetic, and was the first halogenated hydrocarbon anesthetic to be introduced.

EAD-1
(CAS: 1644388-26-0)

EAD-1, a chloroquinoline derivative, has been found to be an autophagy inhibitor that exhibit antiproliferative effct in lung and pancreatic cancer cells so tha...

Rafigrelide
(CAS: 1029711-88-3)

Rafigrelide is a platelet aggregation inhibitor, which plays a central role in atherothrombotic events. It could prolonge clot formation time and reduce clot st...

CAS 112809-51-5 Letrozole

Letrozole
(CAS: 112809-51-5)

Letrozole is a third generation inhibitor of aromatase with IC50 of 0.07-20 nM.

CAS 25301-02-4 Tyloxapol

Tyloxapol
(CAS: 25301-02-4)

Tyloxapol, a nonionic liquid polymer, is a surfactant to aid liquefaction.

CAS 1786-81-8 Prilocaine hydrochloride

Prilocaine hydrochloride
(CAS: 1786-81-8)

Prilocaine hydrochloride is a local anesthetic of the amino amide type.

Azoramide
(CAS: 932986-18-0)

Azoramide is a modulator of the unfolded protein response with antidiabetic activity. It is a dual-function endoplasmic reticulum (ER) modulator in vitro. It im...

CAS 55-06-1 Liothyronine Sodium

Liothyronine Sodium
(CAS: 55-06-1)

Liothyronine Sodium is the most potent form of thyroid hormone acting on the body to increase the basal metabolic rate, affect protein synthesis.

CAS 38260-01-4 Triethylenetetramine Dihydrochloride

Triethylenetetramine Dihydrochloride
(CAS: 38260-01-4)

Triethylenetetramine Hydrochloride is a selective CuII-chelator, undergoing trials for the treatment of heart failure in patients with diabetes.

CAS 20784-50-3 Isobavachalcone

Isobavachalcone
(CAS: 20784-50-3)

Neuroblastoma, the most common solid extracranial neoplasm in children, originates from embryonic neural crest cells that usually form the sympathetic ganglia a...

CAS 612530-44-6 PTP1B-IN-1

PTP1B-IN-1
(CAS: 612530-44-6)

PTP1B-IN-1 is a potent protein tyrosine phosphatase-1B (PTP1B) inhibitor.

Hybendazole hydrochloride
(CAS: 37975-24-9)

Hybendazole hydrochloride is a synthetic bio-active chemical.

Amitifadine
(CAS: 410074-73-6)

Amitifadine is an antidepressant drug candidate which reduces the duration of immobility in the forced swim test in rats with an oral minimum effective dose (ME...

CAS 1197-18-8 Tranexamic Acid

Tranexamic Acid
(CAS: 1197-18-8)

Tranexamic Acid is an antifibrinolytic for blocking lysine-binding sites of plasmin and elastase-derived plasminogen fragments with IC50 of 5 mM.

CAS 491833-29-5 Eliglustat

Eliglustat
(CAS: 491833-29-5)

Eliglustat is a glucosylceramide synthase inhibitor indicated for the long-term treatment of type 1 Gaucher disease in patients who are CYP2D6 extensive metabol...

Chemical Structure

CAS 55395-07-8 IKarisoside A

Quick Inquiry

Verification code

Featured Items